Concord Drugs Ltd — Important, 14-02-2026: Company Update

The company's board has approved the immediate reconstitution of its Audit, Nomination & Remuneration, and Stakeholders’ Relationship Committees. This strategic move ensures compliance with statutory requirements, strengthening corporate governance. The revised committees now consist entirely of Non-Executive Independent Directors, highlighting a focus on independent oversight. This is a positive step for investor confidence, demonstrating commitment to robust internal controls and stakeholder interests.